Home › Antiphospholipid Syndrome › North Carolina
Antiphospholipid Syndrome clinical trials in North Carolina
3 studies for Antiphospholipid Syndrome are looking for participants at sites in North Carolina.
Cities in North Carolina
Daratumumab in Primary Antiphospholipid Syndrome
- Duke University, Durham
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Sep 16, 2026 · NCT05671757Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Universtity of North Carolina at Chapel Hill, Chapel Hill
RecruitingPhase 1
Ages 18 to 85 · All sexes · Updated Jul 22, 2026 · NCT06371417Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome
- Duke University Medical Center, Durham
RecruitingObservational study
All ages · All sexes · Updated May 29, 2026 · NCT00482794From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.